STOCK TITAN

LENSAR to Present at the 32nd Annual Piper Sandler Virtual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

LENSAR, Inc. (NASDAQ: LNSR), a leader in femtosecond laser surgical solutions for cataracts, announced CEO Nick Curtis will present at the 32nd Annual Piper Sandler Virtual Healthcare Conference. The presentation will be available on-demand starting November 23, 2020, at 10 a.m. Eastern Time via the Company’s website. Curtis will also hold one-on-one meetings with investors on December 1 and 2, 2020. Investors can request meetings through Piper Sandler or by contacting Lee Roth.

About LENSAR: LENSAR specializes in advanced laser systems aimed at enhancing surgical outcomes for cataract treatment.

Positive
  • None.
Negative
  • None.

ORLANDO, Fla.--()--LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on femtosecond laser surgical solutions for the treatment of cataracts, today announced that Nick Curtis, Chief Executive Officer will present at the 32nd Annual Piper Sandler Virtual Healthcare Conference. Mr. Curtis’ presentation will be available on-demand beginning at 10:00 a.m. Eastern Time, and can be accessed through the Investors section of the Company's website at https://ir.lensar.com on November 23, 2020 at 10 a.m. Eastern Time. The webcast will be available for two weeks after the presentation has been posted.

Additionally, Mr. Curtis will be participating in one-on-one meetings with conference attendees on December 1 and 2, 2020. Investors interested in meeting with LENSAR management may request a meeting through Piper Sandler, or by contacting Lee Roth at lroth@burnsmc.com.

About LENSAR

LENSAR is a commercial-stage medical device company focused on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining better visual outcomes, efficiency and reproducibility by providing advanced imaging, simplified procedure planning, efficient design and precision.

Contacts

Thomas R. Staab, II, CFO
ir.contact@lensar.com

Lee Roth / Cameron Radinovic
Burns McClellan for LENSAR
lroth@burnsmc.com / cradinovic@burnsmc.com

FAQ

What date will LENSAR present at the Piper Sandler Virtual Healthcare Conference?

LENSAR will present on November 23, 2020, at 10 a.m. Eastern Time.

How can I access LENSAR's presentation from the conference?

The presentation will be available on-demand through LENSAR's website starting November 23, 2020.

When are the one-on-one meetings with LENSAR management scheduled?

The one-on-one meetings are scheduled for December 1 and 2, 2020.

What is the focus of LENSAR's medical technology?

LENSAR focuses on femtosecond laser surgical solutions for cataract treatment.

Who can investors contact to request a meeting with LENSAR management?

Investors can contact Lee Roth or request meetings through Piper Sandler.

LENSAR, Inc.

NASDAQ:LNSR

LNSR Rankings

LNSR Latest News

LNSR Stock Data

125.67M
9.31M
19.57%
42.59%
0.58%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
ORLANDO